TM-Logo-Navy.png
Novotech Appoints Dr. Ian Braithwaite as Vice President, Global Project Management to Lead World-Class Clinical Program Operations
June 26, 2024 20:00 ET | Novotech
Novotech Appoints Dr. Ian Braithwaite as Vice President, Global Project Management to Lead World-Class Clinical Program Operations
Transforming Cancer Care: Novotech Releases Report on Radiopharmaceuticals Global Clinical Trials Landscape
Transforming Cancer Care: Novotech Releases Report on Radiopharmaceuticals Global Clinical Trials Landscape
June 26, 2024 16:41 ET | Novotech
Transforming Cancer Care: Novotech Releases Report on Radiopharmaceuticals Global Clinical Trials Landscape
Novotech Liver Cancer Research Landscape Report Finds 1,700 Trials Initiated Globally
Novotech Liver Cancer Research Landscape Report Finds 1,700 Trials Initiated Globally
June 22, 2024 20:45 ET | Novotech
BOSTON, June 22, 2024 (GLOBE NEWSWIRE) -- Novotech, a global full-service clinical Contract Research Organization (CRO) specializing in partnering with biotech companies to expedite the development...
Novotech Publishes Report on Research into Endometrial Cancer, a Leading Cause of Gynecology Malignancy Mortality
Novotech Publishes Report on Research into Endometrial Cancer, a Leading Cause of Gynecology Malignancy Mortality 
June 20, 2024 22:53 ET | Novotech
BOSTON, June 20, 2024 (GLOBE NEWSWIRE) -- Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of...
TM-Logo-Navy.png
Novotech Launches Dedicated Early Phase Unit for Biotechs Leveraging the Australian and New Zealand Clinical Environment
June 03, 2024 09:35 ET | Novotech
Novotech launches a dedicated early-phase strategic delivery unit focussed on leveraging the unique advantage of ANZ for early-phase clinical development
TM-Logo-Navy.png
Novotech Signs Strategic MOU with Hong Kong-Shenzhen Innovation and Technology Park Limited (HSITPL)
May 29, 2024 22:43 ET | Novotech
Novotech today announced it has signed a Memorandum of Understanding (MOU) with Hong Kong-Shenzhen Innovation and Technology Park Limited (HSITPL).
TM-Logo-Navy.png
Novotech Announces MOU with Experienced Psychedelics Research Center at the 4th Annual Psychedelic Therapeutics and Drug Development Conference in Boston
May 22, 2024 20:11 ET | Novotech
Novotech Announces MOU with Experienced Psychedelics Research Center at the 4th Annual Psychedelic Therapeutics and Drug Development Conference in Boston
TM-Logo-Navy.png
Novotech Appoints Commercial and Clinical Life Sciences Specialist to Head Up Global Drug Development Consulting Team
May 02, 2024 17:00 ET | Novotech
Novotech CRO appoints Scott Schliebner as Vice President and Global Head, Drug Development Consulting (DDC).
Acute Myeloid Leukemia (AML)
Novotech Publishes Research Report on Acute Myeloid Leukaemia Clinical Trial Landscape for Clinical Stage Biotechs
April 10, 2024 22:37 ET | Novotech
The report presents a comprehensive look at the AML funding landscape, trial density, patient recruitment data
Cystic Fibrosis (CF)
Novotech Publishes Analyst Report on Cystic Fibrosis Clinical Trial Landscape to Inform Biotech Research Planning 
April 10, 2024 22:33 ET | Novotech
The report presents a data-backed review of the Cystic Fibrosis (CF) funding landscape, trial density, and patient recruitment data.